China launches pilot for fully digital import drug clearance at Beijing Port, cutting processing to seconds
On September 21, 2026, China's National Medical Products Administration and General Administration of Customs launched a pilot program at Beijing Port for fully online electronic import drug clearance. The system allows companies to submit applications online and instantly download electronic clearance certificates with QR codes, replacing in-person paper collection. Processing time for single-batch import filings is reduced to minutes, with certificate issuance in seconds. The initiative aims to improve trade efficiency and support clinical urgent needs.
IllustrationEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
Beijing Port launches fully online import drug clearance, cutting processing to seconds
On September 21, 2026, China's National Medical Products Administration and the General Administration of Customs announced the launch of a pilot program for electronic import drug clearance at Beijing Port, effective immediately. The program digitizes the entire process, allowing companies to submit applications online and download electronic Import Drug Clearance Certificates instantly upon approval, replacing the previous requirement for in-person collection of paper documents. The electronic certificates, which include QR codes for verification, have the same legal validity as paper versions. The Beijing Municipal Medical Products Administration reported that the first electronic certificate was successfully downloaded, marking a national first. The new system reduces single-batch import registration processing to minutes and certificate issuance to seconds. From January to July 2026, Beijing Port imported pharmaceutical materials and drugs worth 77.34 billion yuan, up 17.2% year-on-year, ranking first nationally. The initiative aims to improve trade efficiency, support clinical urgent needs, and accelerate new drug launches, with officials and industry representatives praising the reduction in logistics time and administrative burden.
Read sourceChina launches pilot for electronic import drug clearance at Beijing ports
China's National Medical Products Administration and the General Administration of Customs have jointly announced a pilot program for electronic import drug (including medicinal herbs) clearance at Beijing ports, effective from September 21. The initiative aims to enhance the digitalization of government services and improve the efficiency and convenience of import drug customs clearance. Under the pilot, electronic customs clearance documents will have the same legal validity as paper documents. During the trial period, existing paper documents will remain valid, and companies can continue to use them as per normal procedures. The move is part of broader efforts to streamline administrative processes and facilitate trade in pharmaceutical products.
Read sourceChina launches pilot for electronic import drug clearance at Beijing ports
China's National Medical Products Administration (NMPA) and the General Administration of Customs (GAC) jointly announced on September 21 that a pilot program for electronic clearance of imported drugs (including medicinal herbs) will begin at Beijing ports. The initiative aims to enhance the digitalization of government services and improve the efficiency and convenience of import drug customs procedures. According to the announcement, electronic clearance documents will have the same legal validity as paper documents. During the pilot period, existing paper documents will remain valid, and companies can continue to use them as per normal regulations. The move is part of broader efforts to streamline cross-border pharmaceutical trade and reduce administrative burdens.
Read sourceShow 3 older updatesHide older updates
China launches pilot for electronic import drug clearance at Beijing ports
China's National Medical Products Administration and the General Administration of Customs jointly announced on September 21 that a pilot program for electronic import drug (including medicinal herbs) clearance will begin at Beijing ports, effective immediately. The initiative aims to further improve the digitalization level of government services and enhance the efficiency and convenience of import drug clearance procedures. Electronic clearance documents will have the same legal validity as paper documents. During the pilot period, existing paper documents will remain valid, and companies can continue to use them normally according to relevant regulations.
Read sourceChina launches pilot for electronic import drug clearance at Beijing ports
China's National Medical Products Administration and the General Administration of Customs jointly announced a pilot program to digitize import drug (including medicinal herbs) customs clearance at Beijing ports. Effective from the date of the announcement, electronic documents will have the same legal validity as paper documents. During the pilot period, existing paper documents remain valid and enterprises can continue to use them as normal. The initiative aims to further improve the digitalization level of government services and enhance the efficiency and convenience of import drug customs clearance. The announcement was reported by Cailian Press and republished by East Money News' industry economy section.
Read sourceChina launches pilot for electronic import drug clearance at Beijing ports
China's National Medical Products Administration and the General Administration of Customs jointly announced a pilot program to digitize the import clearance process for pharmaceuticals (including medicinal herbs) at Beijing ports. Effective immediately, electronic customs documents will carry the same legal weight as paper documents. The initiative aims to improve the efficiency and convenience of import drug clearance while advancing government service digitalization. During the trial period, existing paper-based procedures remain valid, and companies may continue using them as per current regulations. The move is part of broader efforts to streamline cross-border trade in pharmaceuticals and enhance regulatory transparency.
Read source